Technical Analysis for ORTX - Orchard Therapeutics plc

Grade Last Price % Change Price Change
grade B 14.3 -1.79% -0.26
ORTX closed down 1.79 percent on Monday, December 17, 2018, on 1.31 times normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.
0 Watchers
View Intraday Alerts Watchlist Portfolio

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent N/A N/A Down
See historical ORTX trend table...

Date Alert Name Type % Chg
Dec 17 Strong but Oversold Other 0.00%
Dec 17 Down 3 Days in a Row Weakness 0.00%
Dec 17 Down 4 Days in a Row Weakness 0.00%
Dec 17 Oversold Stochastic Weakness 0.00%
Dec 14 Stochastic Reached Oversold Weakness -1.79%
Dec 14 Down 3 Days in a Row Weakness -1.79%
Dec 14 Oversold Stochastic Weakness -1.79%
Dec 13 NR7 Range Contraction -4.67%
Dec 13 NR7-2 Range Contraction -4.67%
Dec 13 Inside Day Range Contraction -4.67%

Older signals for ORTX ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Get Started for Free!
Configure default chart indicators
Basic chart:

Profile
  • Earnings date: ???
Orchard Therapeutics is a fully integrated commercial-stage biopharmaceutical company dedicated to transforming the lives of patients with serious and life-threatening rare diseases through innovative gene therapies. Orchard’s advanced portfolio of autologous ex vivo gene therapies targets serious and life-threatening rare diseases, initially primary immune deficiencies, neurometabolic disorders and hemoglobinopathies.
Is ORTX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 0 bearish and 4 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Date Title
Dec 17 Positive Data From Orchard Therapeutics Turns Goldman Sachs Bullish
Dec 14 Orchard Therapeutics and SIRION Biotech inks deal to enhance gene therapy manufacturing efficiency
Dec 13 Targeting 'bubble baby' disease, this gene therapy company is planting a flag in the East Bay
Dec 13 Orchard Therapeutics Announces the Build-out of New Gene Therapy Manufacturing Facility in California
Dec 7 Orchard Therapeutics Appoints Industry Veteran Alicia Secor to its Board of Directors
Dec 5 Donald B. Kohn, MD, Orchard Therapeutics Scientific Advisory Board Member, Presents Clinical Proof-of-Concept Data for OTL-102 Gene Therapy for the Treatment of Patients with X-CGD at the Presidential Symposium at the 2018 ASH Annual Meeting
Nov 26 Benzinga's Top Upgrades, Downgrades For November 26, 2018
Nov 26 Piper bullish on Novavax in preparket analyst action
Nov 24 Stocks To Watch: Eyes On Cyber Monday, Argentina And Mars
Nov 19 Microcaps dominate midday movers
See more ORTX news...
Indicators
Indicator Value
52 Week High 19.24
52 Week Low 13.0
Average Volume 63,906
200-Day Moving Average 0.0
50-Day Moving Average 0.0
20-Day Moving Average 15.735
10-Day Moving Average 15.135
Average True Range 1.2859
ADX 23.39
+DI 15.5933
-DI 13.7611
Chandelier Exit (Long, 3 ATRs ) 15.3823
Chandelier Exit (Short, 3 ATRs ) 17.8577
Upper Bollinger Band 17.7063
Lower Bollinger Band 13.7637
Percent B (%b) 0.14
BandWidth 25.056244
MACD Line -0.0958
MACD Signal Line 0.0962
MACD Histogram -0.192
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 16.66
Resistance 3 (R3) 16.82 16.19 16.26
Resistance 2 (R2) 16.19 15.59 16.11 16.13
Resistance 1 (R1) 15.25 15.22 14.94 15.09 16.00
Pivot Point 14.62 14.62 14.47 14.54 14.62
Support 1 (S1) 13.68 14.02 13.37 13.52 12.60
Support 2 (S2) 13.05 13.65 12.97 12.47
Support 3 (S3) 12.11 13.05 12.34
Support 4 (S4) 11.95